Allelotype of gastric adenocarcinoma

Aron S. Yustein, Jeffery C. Harper, Gina R. Petroni, Oscar W. Cummings, Christopher A. Moskaluk, Steven M. Powell*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

90 Scopus citations


Gastric adenocarcinoma is a leading cause of cancer mortality worldwide. Yet, the underlying molecular events important in the development of this cancer are largely undefined. Thus, we performed a comprehensive survey for allelic loss on our panel of xenografted human gastric carcinomas. Contaminating normal stromal cells of primary cancers often limit mutational analyses. Xenografted samples of our gastric carcinomas provided optimally enriched tumors for neoplasia that clearly and sensitively demonstrated genetic alterations. Additionally, total absence of allelic signals in these xenografted samples confirmed true loss of alleles rather than just allelic imbalance. Analysis of at least two highly polymorphic microsatellite markers per nonacrocentric chromosomal arm in our xenografted human gastric carcinomas demonstrated significant loss of heterozygosity well above background levels at 3p, 4p, 5q, 8p, 9p, 13q, 17p, and 18q. Several of these loci represent novel findings of significant loss in gastric cancers. On chromosome 17p, p53 is known to be inactivated either by mutation or deletion in a majority of gastric carcinomas. The critical target(s) of inactivation in gastric cancers at these other loci remain to be characterized.

Original languageEnglish
Pages (from-to)1437-1441
Number of pages5
JournalCancer Research
Issue number7
StatePublished - 1 Apr 1999
Externally publishedYes


Dive into the research topics of 'Allelotype of gastric adenocarcinoma'. Together they form a unique fingerprint.

Cite this